Simcere Pharmaceutical Group Limited는 주당 0.00의 연간 배당금을 지급하며, 수익률은 0.00%입니다. 배당금은 연간에 지급되며, 마지막 배당금 지급일은 Jun 18, 2025였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
0.00%
$0.00
Jun 18, 2025
지급 빈도
지급 비율
연간
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
Jun 18, 2025
$0.1748
Jun 19, 2025
Jul 14, 2025
Jun 18, 2024
$0.1757
Jun 19, 2024
Jul 15, 2024
Jun 19, 2023
$0.1758
Jun 20, 2023
Jul 12, 2023
Jun 28, 2022
$0.1757
Jun 29, 2022
Jul 15, 2022
Jun 29, 2021
$0.1803
Jun 30, 2021
Jul 16, 2021
배당금 차트
2096.HK 배당금
2096.HK 배당금 성장률(년간 비교)
Follow-Up Questions
Simcere Pharmaceutical Group Limited의 현재 배당금과 연간 배당금은 얼마인가요?
Simcere Pharmaceutical Group Limited의 배당 성향은 얼마인가요?
2096.HK의 배당락일은 언제인가요?
Simcere Pharmaceutical Group Limited은 얼마나 자주 배당금을 지급하나요?
주요 통계
이전 종가
$11.64
시가
$11.87
일일 범위
$11.5 - $11.87
52주 범위
$6.6 - $15.08
거래량
5.9M
평균 거래량
8.5M
EPS(TTM)
0.40
배당수익률
--
시가총액
$30.1B
SIMCERE PHARMA란 무엇인가요?
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 6,815 full-time employees. The company went IPO on 2020-10-27. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.